Back to Journals » OncoTargets and Therapy » Volume 11

Adverse events risk associated with regorafenib in the treatment of advanced solid tumors: meta-analysis of randomized controlled trials

Total article views   HTML views PDF downloads Totals
10,698 Dovepress* 9,874+ 798 10,672
PubMed Central* 824 232 1,056
Totals 10,698 1,030 11,728
*Since 2 October 2018

View citations on PubMed Central and Google Scholar